29Jul
Financial Daily Dose 7.29.2019 | Top Story: Pfizer and Mylan Join Forces to Create Generics Powerhouse
Drug giants Pfizer and Mylan have inked a deal that will merge the former’s off-patent drugs with the latter’s generics business, a tie-up that creates a mammoth global seller of lower-priced medicines....
By:
Robins Kaplan LLP
Related
On Monday, August 17, 2020, Baker Donelson's Clinton Sanko sat down with Wendell Jisa, CEO of Reveal...
Read More >
Although the construction industry was generally exempted from Governor Jim Justice’s March 23, 202...
Read More >
Following a recent Delaware case, buyers in M&A deals should ensure that their purchase agreements a...
Read More >
Impact of Brexit on Competition matters - On 31 January 2020, the United Kingdom ("UK") ceased to ...
Read More >
The recent Wuhan coronavirus (2019-nCoV) has brought into sharp focus the need for the government an...
Read More >
When we respond to allegations of employment discrimination, reconstructing the timeline of events i...
Read More >